Tuesday, February 25, 2020

(Courtesy of HRH) Hudson Regional Hospital has purchased Surfacide UV-C emitting tower systems that will be used to kill superbugs, or multi-drug-resistant organisms, including C. diff, MRSA, VRE, CRE and Acinetobacter in all its operating suites, labor and delivery suites and isolation rooms.

The Surfacide System

The Surfacide Helios system implements multiple emitters through three towers that disinfect all exposed surfaces of the healthcare environments in a single 20- to 30-minute cycle, offering an effective additional line of defense for the hospital’s maintenance staff.

“The Surfacide machine increases the efficacy of our accredited maintenance program in place to create a safe and clean environment for all our patients and visitors,” said Dr. Nizar Kifaieh, MD MBA, CPE, FACEP, president and CEO of Hudson Regional Hospital. “By allowing us to ‘see’ and reach areas that need to be disinfected in less time, our staff can work more efficiently, and increase the number of patients our doctors can accommodate.”

The Surfacide Helios system is one element of Hudson Regional Hospital’s extensive patient safety and quality of care program, which is accredited by the international standard DNV-GL, the first and only accreditation program to integrate National Integrated Accreditation for Healthcare Organizations (NIAHO®), the CMS Conditions of Participation with the ISO 9001 Quality Management Program (QMS).

Surfacide can detect anyone entering the room and shut off the three emitters instantly, ensuring patient, visitor and employee safety.

The Surfacide Helios system’s main opponent is healthcare-associated infections (HAI) that impact more than 1 million people annually and cost healthcare providers $30 billion in the United States alone. HAIs can even be more dangerous for healthcare consumers, however. HAIs kill more people than prostate and breast cancer combined, and a hospital stay is on average lengthened 17.6. days when an HAI is contracted.

The Surfacide Helios system complements Hudson Regional Hospital’s already standout cleanliness environment. In 2018, Hudson Regional Hospital was in the 90th percentile for “Cleanliness of Hospital Environment” according to the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS). Right now, Hudson Regional Hospital is averaging a cleanliness score 3.6% higher than the rest of New Jersey and is 18% cleaner than the average national hospital.

An Investment in Technology

Together with the da Vinci Xi Robotic Surgery System and the ExcelsiusGPS Robotic Guidance and Navigation System, the Surfacide Helios system represents another significant investment in state-of-the-art medical robotic technology for Hudson Regional Hospital.

Considered one of the most dynamic tools for robotic surgery in the world, the da Vinci robotic surgery system delivers a high degree of fidelity and precision in the control of surgical instruments. Operated by a trained surgeon—who is in full control throughout the procedure—utilizing dedicated equipment, the system improves comfort for both surgeons and patients alike.

The ExcelsisusGPS, on the other hand, offers decreased operation times, reduced exposure to radiation and increased accuracy through its compatibility with computed tomography (CT), intra-operative CT and fluoroscopic imaging modalities.

Patients who qualify for this procedure should anticipate faster recovery times; less blood loss and muscle damage; and smaller incisions, which will reduce infection risk, nerve damage and scarring.

About Hudson Regional Hospital

Hudson Regional Hospital offers preventive and other services both on an inpatient and outpatient basis. Patients can inquire about these services or schedule appointments by contacting the hospital directly, either via telephone at 201-392-3100 or email at [email protected] Patients facing medical emergencies should proceed directly to the emergency room. The emergency room contact number is 201-392-3210.